Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis Simona F. ShaitelmanYi-Ju ChiangJanice N. Cormier Review 23 December 2016 Pages: 201 - 215
Erratum to: Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis Simona F. ShaitelmanYi-Ju ChiangJanice N. Cormier Erratum 09 February 2017 Pages: 217 - 217
Surgical treatment of secondary lymphedema of the upper limb by stepped microsurgical lymphaticovenous anastomoses Marie-Anne PoumellecRémi FoissacTarik Ihrai Review 12 January 2017 Pages: 219 - 224
Breast cancer screening of pregnant and breastfeeding women with BRCA mutations Harris CarmichaelCindy MatsenSarah Colonna Review 30 January 2017 Pages: 225 - 230
GDNF induces RET–SRC–HER2-dependent growth in trastuzumab-sensitive but SRC-independent growth in resistant breast tumor cells Mossa GardanehSahar ShojaeiBabak Behnam Preclinical study 23 January 2017 Pages: 231 - 241
FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis Marit VallaMonica Jernberg EngstrømAnna Mary Bofin Preclinical study 25 January 2017 Pages: 243 - 253
A comparison of serum miRNAs influencing metastatic growth of EMT6 vs 4THM tumor cells in wild-type and CD200R1KO mice Reginald M. GorczynskiFang ZhuIsmat Khatri Preclinical study 03 February 2017 Pages: 255 - 266
Oncoplastic surgery with omental flap reconstruction: a study of 200 cases Hisamitsu ZahaNorie AbeMikiko Unesoko Clinical trial 24 January 2017 Pages: 267 - 274
Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral Laura H. RosenbergerRyan WeberMelissa L. Pilewskie Clinical trial 28 January 2017 Pages: 275 - 282
Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging David A. StrahleDorothy R. PathakKiran Devisetty Clinical trial Open access 30 January 2017 Pages: 283 - 295
Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer Jada G. HamiltonMargaux C. GenoffMark E. Robson Clinical trial 01 February 2017 Pages: 297 - 306
Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study Alexandre de NonnevilleAnthony GonçalvesGilles Houvenaeghel Clinical trial 02 February 2017 Pages: 307 - 316
Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States Yasmin HasanJoseph WallerDezheng Huo Epidemiology 24 January 2017 Pages: 317 - 328
Accelerated partial breast irradiation compared with whole breast radiation therapy: a breast cancer cohort study measuring change in radiation side-effects severity and quality of life M. PérezM. SchootmanD. B. Jeffe Epidemiology 28 January 2017 Pages: 329 - 342
Determinants of volumetric breast density in Chilean premenopausal women Ana PereiraMaria Luisa GarmendiaJohn Shepherd Epidemiology 28 January 2017 Pages: 343 - 352
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers Marc B.I. LobbesIngeborg J.H. VriensVivianne C.G. Tjan-Heijnen Epidemiology Open access 28 January 2017 Pages: 353 - 364
Inflammatory breast cancer in the Netherlands; improved survival over the last decades D. J. P. van UdenR. BretveldC. F. J. M. Blanken-Peeters Epidemiology 30 January 2017 Pages: 365 - 374
Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review Kirsten A. NyropAllison M. DealShlomit S. Shachar Epidemiology 02 February 2017 Pages: 375 - 388
Metabolic syndrome and incidence of breast cancer in middle-aged Korean women: a nationwide cohort study Jung Ah LeeJung Eun YooHye Soon Park Brief Report 01 February 2017 Pages: 389 - 393
Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival? Kadri Altundag Letter to the Editor 16 January 2017 Pages: 395 - 396
Response to “Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?” Wendie D. den BrokCaroline H. SpeersCaroline A. Lohrisch Rebuttal Letter 21 January 2017 Pages: 397 - 398
